Drug Shortage Report for JANUMET XR

Last updated on 2021-12-15 History
Report ID 150721
Drug Identification Number 02416808
Brand name JANUMET XR
Common or Proper name sitagliptin and metformin hydrochloride modified-release tablets
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) METFORMIN HYDROCHLORIDE SITAGLIPTIN
Strength(s) 1000MG 100MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 30
ATC code A10BD
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Other (Please describe in comments)
Anticipated start date 2021-12-14
Actual start date 2021-12-13
Estimated end date 2021-12-20
Actual end date 2021-12-14
Shortage status Resolved
Updated date 2021-12-15
Company comments Expected shortage due to quality testing delay.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-12-15 English Compare
v10 2021-12-14 French Compare
v9 2021-12-14 English Compare
v8 2021-12-14 English Compare
v7 2021-12-13 French Compare
v6 2021-12-13 English Compare
v5 2021-12-08 French Compare
v4 2021-12-08 English Compare
v3 2021-12-08 French Compare
v2 2021-12-08 English Compare
v1 2021-12-08 English Compare

Showing 1 to 11 of 11